HD 18 for advanced stages: treatment optimization trial in the first line treatment of advanced stage Hodgkin Lymphoma; treatment stratification by means of FDG-PET.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Rituximab (Primary) ; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Procarbazine; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 24 Jun 2017 According to a media release, data was presented at the European Hematology Association (EHA) annual congress 2017.
- 12 Feb 2017 Results of second planned interim analysis (n=1100) results published in the Lancet Oncology.
- 17 Mar 2012 Planned end date (17 Apr 2018) added as reported by European Clinical Trials Database.